GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » The Cooper Companies Inc (MEX:COO) » Definitions » Cyclically Adjusted PS Ratio

The Cooper (MEX:COO) Cyclically Adjusted PS Ratio : 5.84 (As of Jan. 18, 2025)


View and export this data going back to 2014. Start your Free Trial

What is The Cooper Cyclically Adjusted PS Ratio?

As of today (2025-01-18), The Cooper's current share price is MXN1873.00. The Cooper's Cyclically Adjusted Revenue per Share for the quarter that ended in Oct. 2024 was MXN320.77. The Cooper's Cyclically Adjusted PS Ratio for today is 5.84.

The historical rank and industry rank for The Cooper's Cyclically Adjusted PS Ratio or its related term are showing as below:

MEX:COO' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 4.23   Med: 6.71   Max: 9.78
Current: 5.82

During the past years, The Cooper's highest Cyclically Adjusted PS Ratio was 9.78. The lowest was 4.23. And the median was 6.71.

MEX:COO's Cyclically Adjusted PS Ratio is ranked worse than
74.31% of 436 companies
in the Medical Devices & Instruments industry
Industry Median: 2.285 vs MEX:COO: 5.82

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

The Cooper's adjusted revenue per share data for the three months ended in Oct. 2024 was MXN101.644. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is MXN320.77 for the trailing ten years ended in Oct. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


The Cooper Cyclically Adjusted PS Ratio Historical Data

The historical data trend for The Cooper's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Cooper Cyclically Adjusted PS Ratio Chart

The Cooper Annual Data
Trend Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.49 8.71 5.01 5.25 6.53

The Cooper Quarterly Data
Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.25 6.19 5.74 5.92 6.53

Competitive Comparison of The Cooper's Cyclically Adjusted PS Ratio

For the Medical Instruments & Supplies subindustry, The Cooper's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


The Cooper's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, The Cooper's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where The Cooper's Cyclically Adjusted PS Ratio falls into.



The Cooper Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

The Cooper's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=1873.00/320.77
=5.84

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Cooper's Cyclically Adjusted Revenue per Share for the quarter that ended in Oct. 2024 is calculated as:

For example, The Cooper's adjusted Revenue per Share data for the three months ended in Oct. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Oct. 2024 (Change)*Current CPI (Oct. 2024)
=101.644/133.1820*133.1820
=101.644

Current CPI (Oct. 2024) = 133.1820.

The Cooper Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201501 34.024 98.604 45.956
201504 34.008 99.824 45.373
201507 37.644 100.691 49.791
201510 38.166 100.346 50.655
201601 41.945 99.957 55.887
201604 42.518 100.947 56.095
201607 49.267 101.524 64.630
201610 49.414 101.988 64.528
201701 52.627 102.456 68.409
201704 49.955 103.167 64.489
201707 50.048 103.278 64.539
201710 53.812 104.070 68.865
201801 56.169 104.578 71.532
201804 59.730 105.708 75.254
201807 61.744 106.324 77.341
201810 65.981 106.695 82.361
201901 59.954 106.200 75.186
201904 62.141 107.818 76.759
201907 64.390 108.250 79.220
201910 66.304 108.577 81.329
202001 61.402 108.841 75.134
202004 63.440 108.173 78.107
202007 64.904 109.318 79.073
202010 73.093 109.861 88.609
202101 69.334 110.364 83.669
202104 72.996 112.673 86.283
202107 76.056 115.183 87.941
202110 77.846 116.696 88.844
202201 81.390 118.619 91.382
202204 84.979 121.978 92.784
202207 86.563 125.002 92.228
202210 84.673 125.734 89.688
202301 81.218 126.223 85.696
202304 79.228 127.992 82.441
202307 77.913 128.974 80.455
202310 83.852 129.810 86.030
202401 80.047 130.124 81.928
202404 80.223 132.289 80.764
202407 92.969 132.708 93.301
202410 101.644 133.182 101.644

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


The Cooper  (MEX:COO) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


The Cooper Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of The Cooper's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


The Cooper Business Description

Address
6101 Bollinger Canyon Road, Suite 500, San Ramon, CA, USA, 94583
CooperCompanies is one of the largest eyecare companies in the us. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the us contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the us, and controls 17% of the us IUD market.